Fig. 1From: Long-term outcome of percutaneous radiofrequency ablation for periportal hepatocellular carcinoma: tumor recurrence or progression, survival and clinical significanceThe flow diagram showing exclusion criteria in patients with hepatocellular carcinoma (HCC) who underwent radiofrequency ablation (RFA) or transarterial chemoembolization (TACE) combined with RFA (TACE+RFA)Back to article page